HCA
MED icon

Harbor Capital Advisors’s Medifast MED Stock Holding History

Harbor Capital Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-422
Closed -$6K – 1431
2025
Q2 		$6K Buy
422
+71
+20% +$933 ﹤0.01% 1122
2025
Q1 		$5K Buy
351
+42
+14% +$631 ﹤0.01% 1189
2024
Q4 		$5K Sell
309
-4
-1% -$74 ﹤0.01% 1128
2024
Q3 		$6K Buy
+313
New +$6.03K ﹤0.01% 1099

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Harbor Capital Advisors's MED Position: Q3 2025 in Review

Harbor Capital Advisors sold out of Medifast (MED) in Q3 2025, closing a stake of 422 shares — an estimated $6K sold.

Harbor Capital Advisors first reported a position in MED in Q3 2024 and held it in 4 quarters. The position peaked at $6K in Q2 2025. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

  • Harbor Capital Advisors reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
  • Harbor Capital Advisors sold 422 Medifast shares in Q3 2025, an estimated $6K.
  • Harbor Capital Advisors first reported a position in Medifast in Q3 2024 and held it in 4 quarters.
  • Harbor Capital Advisors's Medifast position peaked at $6K in Q2 2025.
  • 123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Harbor Capital Advisors's 13F filing for Q3 2025, filed 15 Oct 2025.